Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

July 19, 2017

Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

The Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis which was published in the International journal of antimicrobial agents. Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis - International Journal of Antimicrobial Agents Human African trypanosomiasis (HAT) is a neglected tropical disease, with a population of 70 million at risk. Current treatment options are limited.

In the search for new therapeutics, the repurposing of the broad-spectrum antiprotozoal drug fexinidazole has completed Phase III trials with the anticipation that it will be the first oral treatment for HAT.

For more information please see - https://www.sciencedirect.com/journal/international-journal-of-antimicrobial-agents

< Older Post

Newer Post >

🌟 Pharmidex at the @Immuno-Oncology & Biomarker Summit 2026

March 16, 2026

Pharmidex is proud to be the Networking Sponsor at the Immuno-Oncology & Biomarker Summit in London. Over the next two days, the event provides an opportunity to discuss the latest advances in immuno-oncology, biomarker discovery, and precision medicine. If you’re attending, come and say hello to Ash Alavijeh to connect and explore opportunities to collaborate.

🔬 Pharmidex at Mastering Medicinal Chemistry X

March 13, 2026

We’re excited to announce that Janette Dalay Robertson , Business Development Manager at Pharmidex , will be attending and exhibiting at the 10th RSC-BMCS Symposium on Mastering Medicinal Chemistry on Friday 13 March 2026 at Burlington House, London. Pharmidex is also proud to be sponsoring this fantastic event, which brings together leaders and innovators from across the medicinal chemistry community. If you’re attending, make sure to stop by and speak with Janette at the Pharmidex stand. She will be delighted to connect, discuss your research, and explore how Pharmidex can support your drug discovery and development programmes. 🤝 We look forward to meeting fellow scientists, collaborators, and partners at this exciting meeting.

🚀 Pharmidex at Cell & Gene Therapy 2026

March 9, 2026

We are pleased to share that Janette Dalay Robertson will be attending Cell & Gene Therapy 2026 taking place 9–10 March 2026 at Hinxton Hall Conference Centre, Cambridge. This event is a fantastic opportunity to connect with leaders across the cell and gene therapy ecosystem and Janette will be there representing Pharmidex and discussing how our scientific services support drug discovery and development. 🤝 Janette would be delighted to meet with fellow attendees to: • Explore new collaborations • Discuss upcoming research programs • Share how Pharmidex can support innovative therapeutic development If you are attending, feel free to reach out and arrange a meeting during the event. We look forward to engaging conversations and building new partnerships within the cell and gene therapy community!